Literature DB >> 23362880

Effects of early oral feeding on relapse and symptoms of upper gastrointestinal bleeding in peptic ulcer disease.

Manouchehr Khoshbaten1, Saeideh Ghaffarifar, Afshin Jabbar Imani, Tahere Shahnazi.   

Abstract

BACKGROUND: Peptic ulcer is the most common cause of upper gastrointestinal bleeding (GIB) and nutritional support is a helpful strategy in malnutrition prevention during treatment. As early oral feeding in patients with GIB may shorten hospital stay and decrease costs and risk of infection, the present study was carried out to investigate the effects of early oral feeding on relapse and symptoms of upper GIB.
METHODS: The present clinical trial was conducted with the participation of 100 patients with upper GIB due to gastric or duodenum ulcer at Emam Reza University Hospital in Tabriz. Subjects were randomly allocated to two groups (n=50). In one group, patients received oral diet from day 1 and in other group patients were nil by mouth until day 3 and then received oral diet. Endoscopic and clinical findings of patients were recorded from day 1 to 3.
RESULTS: The mean age of subjects was 57.6±1.7 and 63% were male. Sclerotherapy was used in most cases as a hemostasis treatment. There was no significant difference in laboratory findings and rebleeding between the two groups. In the group with early oral feeding, the time of hospital stay was significantly shorter than in the control group (P<0.001).
CONCLUSION: Although early oral feeding had no significant effects on electrolyte balance and treatment outcomes in patients with upper GIB who were treated with endoscopic hemostasis, it could effectively shorten the hospital stay. Consequently, early oral feeding in these patients enables early discharge and reduces the costs of treatment.
© 2012 The Authors. Digestive Endoscopy © 2012 Japan Gastroenterological Endoscopy Society.

Entities:  

Mesh:

Year:  2012        PMID: 23362880     DOI: 10.1111/j.1443-1661.2012.01347.x

Source DB:  PubMed          Journal:  Dig Endosc        ISSN: 0915-5635            Impact factor:   7.559


  5 in total

1.  Safety and patient satisfaction of early diet after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective, randomized study.

Authors:  Sunyong Kim; Kyung Seok Cheoi; Hyun Jik Lee; Choong Nam Shim; Hyun Soo Chung; Hyuk Lee; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee; Jun Chul Park
Journal:  Surg Endosc       Date:  2013-12-12       Impact factor: 4.584

Review 2.  Early enteral nutrition in critically ill patients: ESICM clinical practice guidelines.

Authors:  Annika Reintam Blaser; Joel Starkopf; Waleed Alhazzani; Mette M Berger; Michael P Casaer; Adam M Deane; Sonja Fruhwald; Michael Hiesmayr; Carole Ichai; Stephan M Jakob; Cecilia I Loudet; Manu L N G Malbrain; Juan C Montejo González; Catherine Paugam-Burtz; Martijn Poeze; Jean-Charles Preiser; Pierre Singer; Arthur R H van Zanten; Jan De Waele; Julia Wendon; Jan Wernerman; Tony Whitehouse; Alexander Wilmer; Heleen M Oudemans-van Straaten
Journal:  Intensive Care Med       Date:  2017-02-06       Impact factor: 17.440

3.  Efficacy and safety of Jianzhong decoction in treating peptic ulcers: a meta-analysis of 58 randomised controlled trials with 5192 patients.

Authors:  Yan Sun; Jinping Zhang; Yuanyuan Chen
Journal:  BMC Complement Altern Med       Date:  2017-04-14       Impact factor: 3.659

Review 4.  Early enteral nutrition versus delayed enteral nutrition in patients with gastrointestinal bleeding: A PRISMA-compliant meta-analysis.

Authors:  Hongyan Zhang; Yu Wang; Shujun Sun; Xin Huang; Guangjie Tu; Jingxu Wang; Yun Lin; Haifa Xia; Yin Yuan; Shanglong Yao
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

Review 5.  COVID-19 in a young man with hypertension: A case study of missed opportunities in intensive progression.

Authors:  Kun Rao; Liuzhao Xie; Jianyu Wu; Tianbo Weng; Leile Tang; Jieying Zhou
Journal:  Intensive Crit Care Nurs       Date:  2020-06-01       Impact factor: 3.072

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.